I want everyone to stop and ask what interest Google has in releasing mosquitoes. They’re a tech company. Not an environmental group. Not a non-profit. Not a government. A tech company. Just like Bill Gates, I don’t want them anywhere near our wildlife or nature. CC: @LeeMZeldin
I am done with the Republican Party.
Between this and Thune’s refusal to pass the SAVE Act, I’m done with these uniparty traitors.
I’m changing my party affiliation to Independent. No wonder President Trump is fighting an uphill battle every day.
BREAKING: Transportation Secretary Sean Duffy confirms the driver of the bus that crashed into a line of cars in Virginia, kiIIing 5 and injuring 34, is a Chinese national who became a U.S. citizen and DOESN’T SPEAK ENGLISH.
He got his CDL from Democrat Kathy Hochul’s New York.
🚨 BREAKING: FBI has just RAIDED and ARRESTED the man who I caught on video threatening the lives of an ICE agent and his family outside ICE Newark
Nicholas Scelfo is facing FEDERAL FELONIES
THIS IS HOW IT’S DONE! 🔥
THANK YOU to @FBIDirectorKash and @DAGToddBlanche for PERSONALLY working with me on this.
You PROMISED you’d find him, and you delivered.
WELL DONE! 👏
ACTING AG BLANCHE: “FAFO.”
And this is:
George Hill, an FBI agent and whistleblower who worked at the FBI Washington, D.C., field office:
— He testified under oath that the FBI would not allow over 11,000 hours of J6 footage to be released because it would expose undercover agents and confidential human sources committing crimes inside the Capitol.
— Additionally, over 5,000 FBI agents were forced to fabricate charges against American citizens.
— And virtually every single FBI whistleblower who came forward was retaliated against.
Mosques are popping up like a fungus in every city in the U.S. Yet so many Americans are asking why are they stopping traffic to “pray” in the streets. It’s not about prayer, folks. It’s a declaration of war. The invaders are declaring their ownership.
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson